Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jul 22, 2024

BUY
$151.44 - $200.09 $114,942 - $151,868
759 Added 41.84%
2,573 $508 Million
Q3 2023

Jul 22, 2024

BUY
$167.14 - $192.77 $303,191 - $349,684
1,814 New
1,814 $316 Million
Q2 2023

Aug 26, 2024

BUY
$160.94 - $186.23 $388,670 - $449,745
2,415 New
2,415 $416 Million
Q4 2022

Sep 06, 2024

SELL
$131.14 - $157.47 $32,522 - $39,052
-248 Reduced 8.42%
2,696 $395 Million
Q3 2022

Sep 06, 2024

BUY
$148.29 - $182.55 $436,565 - $537,427
2,944 New
2,944 $437 Million
Q2 2022

Sep 06, 2024

SELL
$155.97 - $200.09 $413,008 - $529,838
-2,648 Reduced 45.73%
3,142 $540 Million
Q1 2022

Sep 06, 2024

BUY
$181.39 - $234.03 $1.05 Million - $1.36 Million
5,790 New
5,790 $1.09 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track World Equity Group, Inc. Portfolio

Follow World Equity Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on World Equity Group, Inc. with notifications on news.